Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis Infections
Introduction: Today, orthopedic prostheses are being increasingly utilized in people with degenerative joint disease. In these patients, the aim is to increase the quality of life. However, associated infections, most commonly caused by staphylococci, sometimes result in a decrease in the quality of...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Bilimsel Tip Yayinevi
2010-09-01
|
Series: | Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi |
Subjects: | |
Online Access: | http://www.floradergisi.org/getFileContent.aspx?op=REDPDF&file_name=2010-15-3-118-122.pdf |
_version_ | 1797919392716029952 |
---|---|
author | Sevil SAPMAZ KARABAĞ Vildan AVKAN OĞUZ Nur YAPAR |
author_facet | Sevil SAPMAZ KARABAĞ Vildan AVKAN OĞUZ Nur YAPAR |
author_sort | Sevil SAPMAZ KARABAĞ |
collection | DOAJ |
description | Introduction: Today, orthopedic prostheses are being increasingly utilized in people with degenerative joint disease. In these patients, the aim is to increase the quality of life. However, associated infections, most commonly caused by staphylococci, sometimes result in a decrease in the quality of life. Therefore, we aimed to investigate the results of outpatient parenteral teicoplanin treatment. Patients and Methods: Fourteen patients between January 2006 and December 2007 retrospectively and 18 patients between January and December 2008 prospectively were included. Possible prosthesis infection was diagnosed by erythema, swelling, temperature increase in the operation area, and elevation of erythrocyte sedimentation rate and C-reactive protein levels. Teicoplanin (1 x 800 mg/day) was given to patients in whom methicillin-resistant staphylococci were isolated in at least two microbiological cultures taken during the prosthesis removal or in aspiration culture. Patients were followed up weekly. Results: Totally, 32 joint prosthesis patients infected with staphylococci were followed. Methicillin-resistant coagulase-negative staphylococci (75%) were the most common strain (24 patients), followed by methicillin-resistant Staphylococcus aureus (15.6%) (5 patients). Methicillin-susceptible coagulase-negative staphylococci were diagnosed in 2 (6.3%) patients and methicillin-susceptible S. aureus (3.1%) in 1 patient. The difference between mean C-reactive protein values before and after treatment was found to be significant (p= 0.000). Surgical debridement and teicoplanin treatment was successful in 87.5% of the cases; without surgical debridement, the treatment success rate was 71.9%. The cost of therapy for patients treated with outpatient teicoplanin therapy regimen was found lower than for the others treated with hospitalization. Conclusion: C-reactive protein remains the most valuable marker in the prosthesis infection diagnosis and follow-up. As we observed no side effects and the treatment success was high and effective, outpatient parenteral teicoplanin treatment can be an appropriate choice for joint prosthesis infections. |
first_indexed | 2024-04-10T13:44:48Z |
format | Article |
id | doaj.art-ab55b049dfa34bd88d702f12b6fcf42f |
institution | Directory Open Access Journal |
issn | 1300-932X 1300-932X |
language | English |
last_indexed | 2024-04-10T13:44:48Z |
publishDate | 2010-09-01 |
publisher | Bilimsel Tip Yayinevi |
record_format | Article |
series | Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi |
spelling | doaj.art-ab55b049dfa34bd88d702f12b6fcf42f2023-02-15T16:11:01ZengBilimsel Tip YayineviFlora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi1300-932X1300-932X2010-09-01153118122Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis InfectionsSevil SAPMAZ KARABAĞ0Vildan AVKAN OĞUZ1Nur YAPAR2Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, University of Dokuz Eylul, Izmir, TurkeyDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, University of Dokuz Eylul, Izmir, TurkeyDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, University of Dokuz Eylul, Izmir, TurkeyIntroduction: Today, orthopedic prostheses are being increasingly utilized in people with degenerative joint disease. In these patients, the aim is to increase the quality of life. However, associated infections, most commonly caused by staphylococci, sometimes result in a decrease in the quality of life. Therefore, we aimed to investigate the results of outpatient parenteral teicoplanin treatment. Patients and Methods: Fourteen patients between January 2006 and December 2007 retrospectively and 18 patients between January and December 2008 prospectively were included. Possible prosthesis infection was diagnosed by erythema, swelling, temperature increase in the operation area, and elevation of erythrocyte sedimentation rate and C-reactive protein levels. Teicoplanin (1 x 800 mg/day) was given to patients in whom methicillin-resistant staphylococci were isolated in at least two microbiological cultures taken during the prosthesis removal or in aspiration culture. Patients were followed up weekly. Results: Totally, 32 joint prosthesis patients infected with staphylococci were followed. Methicillin-resistant coagulase-negative staphylococci (75%) were the most common strain (24 patients), followed by methicillin-resistant Staphylococcus aureus (15.6%) (5 patients). Methicillin-susceptible coagulase-negative staphylococci were diagnosed in 2 (6.3%) patients and methicillin-susceptible S. aureus (3.1%) in 1 patient. The difference between mean C-reactive protein values before and after treatment was found to be significant (p= 0.000). Surgical debridement and teicoplanin treatment was successful in 87.5% of the cases; without surgical debridement, the treatment success rate was 71.9%. The cost of therapy for patients treated with outpatient teicoplanin therapy regimen was found lower than for the others treated with hospitalization. Conclusion: C-reactive protein remains the most valuable marker in the prosthesis infection diagnosis and follow-up. As we observed no side effects and the treatment success was high and effective, outpatient parenteral teicoplanin treatment can be an appropriate choice for joint prosthesis infections.http://www.floradergisi.org/getFileContent.aspx?op=REDPDF&file_name=2010-15-3-118-122.pdfOrthopedicsProsthesis-related infectionsTeicoplanin |
spellingShingle | Sevil SAPMAZ KARABAĞ Vildan AVKAN OĞUZ Nur YAPAR Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis Infections Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi Orthopedics Prosthesis-related infections Teicoplanin |
title | Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis Infections |
title_full | Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis Infections |
title_fullStr | Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis Infections |
title_full_unstemmed | Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis Infections |
title_short | Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis Infections |
title_sort | evaluation of outpatient parenteral teicoplanin treatment results in staphylococcal orthopedic prosthesis infections |
topic | Orthopedics Prosthesis-related infections Teicoplanin |
url | http://www.floradergisi.org/getFileContent.aspx?op=REDPDF&file_name=2010-15-3-118-122.pdf |
work_keys_str_mv | AT sevilsapmazkarabag evaluationofoutpatientparenteralteicoplanintreatmentresultsinstaphylococcalorthopedicprosthesisinfections AT vildanavkanoguz evaluationofoutpatientparenteralteicoplanintreatmentresultsinstaphylococcalorthopedicprosthesisinfections AT nuryapar evaluationofoutpatientparenteralteicoplanintreatmentresultsinstaphylococcalorthopedicprosthesisinfections |